Patent Number: 8,067,441

Title: Use of collismycin and derivatives thereof as oxidative stress inhibitors

Abstract: The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment of oxidative stress-induced diseases or conditions, especially neurodegenerative diseases, such as Alzheimer's Disease and Parkinson's Disease.

Inventors: Gil; Ana Martinez (Madrid, ES), Egea; Paola Usan (Alpedrete-Madrid, ES), Padilla; Miguel Medina (Madrid, ES), Palomero; Esther Garcia (Leganes-Madrid, ES), Baz; Julia Perez (Trobajo Del Camino-Leon, ES), Chimeno; Rosa Isabel Fernandez (Navatejera-Leon, ES), Fernandez; Antonio Medarde (Leon, ES), Hernandez; Librada Maria Canedo (Onzonilla-Leon, ES), Millan; Francisco Romero (Onzonilla-Leon, ES), Morera; Ana Castro (Madrid, ES), Cascon; Mercedes Alonso (Madrid, ES), Quesada; Jorge Sanchez (Tres Cantos-Madrid, ES)

Assignee: Neuropharma, S.A.

International Classification: A01N 43/40 (20060101); A61K 31/44 (20060101)

Expiration Date: 2020-11-29 0:00:00